These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 31435903)
1. Inhibiting exosomal MIC-A and MIC-B shedding of cancer cells to overcome immune escape: new insight of approved drugs. Moloudizargari M; Asghari MH; Mortaz E Daru; 2019 Dec; 27(2):879-884. PubMed ID: 31435903 [TBL] [Abstract][Full Text] [Related]
2. Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity. Janji B; Berchem G; Chouaib S Front Immunol; 2018; 9():887. PubMed ID: 29922284 [TBL] [Abstract][Full Text] [Related]
3. Exosome mediated communication within the tumor microenvironment. Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224 [TBL] [Abstract][Full Text] [Related]
4. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells. Kim N; Kim HS Front Immunol; 2018; 9():2041. PubMed ID: 30250471 [TBL] [Abstract][Full Text] [Related]
5. Cancer Exosomes as Conveyors of Stress-Induced Molecules: New Players in the Modulation of NK Cell Response. Vulpis E; Soriani A; Cerboni C; Santoni A; Zingoni A Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30708970 [TBL] [Abstract][Full Text] [Related]
6. Natural killer group 2D receptor and its ligands in cancer immune escape. Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924 [TBL] [Abstract][Full Text] [Related]
7. Human NK cells: From surface receptors to clinical applications. Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471 [TBL] [Abstract][Full Text] [Related]
8. Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies. Matosevic S J Immunol Res; 2018; 2018():4054815. PubMed ID: 30306093 [TBL] [Abstract][Full Text] [Related]
9. NK cells to cure cancer. Di Vito C; Mikulak J; Zaghi E; Pesce S; Marcenaro E; Mavilio D Semin Immunol; 2019 Feb; 41():101272. PubMed ID: 31085114 [TBL] [Abstract][Full Text] [Related]
13. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity? Zhang C; Zhang J; Wei H; Tian Z Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316 [TBL] [Abstract][Full Text] [Related]
14. Tricking the balance: NK cells in anti-cancer immunity. Pahl J; Cerwenka A Immunobiology; 2017 Jan; 222(1):11-20. PubMed ID: 26264743 [TBL] [Abstract][Full Text] [Related]
15. Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity. Büll C; Boltje TJ; Balneger N; Weischer SM; Wassink M; van Gemst JJ; Bloemendal VR; Boon L; van der Vlag J; Heise T; den Brok MH; Adema GJ Cancer Res; 2018 Jul; 78(13):3574-3588. PubMed ID: 29703719 [TBL] [Abstract][Full Text] [Related]